Eversept Partners, LP Gsk PLC Call Options Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Nov 08, 2023	BUY	$40.23 - $47.74 $62.5 Million - $74.2 Million	1,553,700 New	1,553,700 $69 Million
Q3 2021 Nov 08, 2023	BUY	$38.79 - $43.16 $3.88 Million - $4.32 Million	100,000 Added 7.12%	1,503,700 $58.6 Million
Q2 2021 Nov 08, 2023	BUY	$36.52 - $41.46 $9.12 Million - $10.3 Million	249,600 Added 21.63%	1,403,700 $57 Million
Q1 2021 Nov 08, 2023	BUY	$34.27 - $40.01 $27.5 Million - $32.1 Million	801,500 Added 227.31%	1,154,100 $42 Million
Q4 2020 Nov 08, 2023	BUY	$34.07 - $39.94 $12 Million - $14.1 Million	352,600 New	352,600 $13.2 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.